Cargando…
Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function
TCR-gene-transfer is an efficient strategy to produce therapeutic T cells of defined antigen specificity. However, there are substantial variations in the cell surface expression levels of human TCRs, which can impair the function of engineered T cells. Here we demonstrate that substitutions of 3 am...
Autores principales: | Thomas, Sharyn, Mohammed, Fiyaz, Reijmers, Rogier M., Woolston, Annemarie, Stauss, Theresa, Kennedy, Alan, Stirling, David, Holler, Angelika, Green, Louisa, Jones, David, Matthews, Katherine K., Price, David A., Chain, Benjamin M., Heemskerk, Mirjam H. M., Morris, Emma C., Willcox, Benjamin E., Stauss, Hans J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773850/ https://www.ncbi.nlm.nih.gov/pubmed/31575864 http://dx.doi.org/10.1038/s41467-019-12441-w |
Ejemplares similares
-
Modifications outside CDR1, 2 and 3 of the TCR variable β domain increase TCR expression and antigen-specific function
por: Degirmencay, Abdullah, et al.
Publicado: (2023) -
Forced Fox-P3 expression can improve the safety and antigen-specific function of engineered regulatory T cells
por: McGovern, Jenny, et al.
Publicado: (2022) -
Engineering CD4+ T Cells to Enhance Cancer Immunity
por: Sillito, Francesca, et al.
Publicado: (2020) -
A Study of T Cell Tolerance to the Tumor-Associated Antigen MDM2: Cytokines Can Restore Antigen Responsiveness, but Not High Avidity T Cell Function
por: Bendle, Gavin M., et al.
Publicado: (2007) -
Safety and efficacy of Tet-regulated IL-12 expression in cancer-specific T cells
por: Alsaieedi, Ahdab, et al.
Publicado: (2018)